Company intelligence / Profile preview

RQ Biotechnology Ltd

London W12, London, United Kingdom

Ownership: Private
Development stage: Phase 1

Overview

The first discovered monoclonal antibody by RQ Bio, AZD3152, entered clinical trials within less than a year after discovery as part of AstraZeneca’s SUPERNOVA Phase I/III trial evaluating safety and neutralizing activity against COVID‑19. This rapid progression demonstrates the effectiveness of their antibody discovery platform. Other pipeline programs remain in preclinical stages targeting influenza, CMV, RSV[1][4][8].

Therapeutic areas: Infectious Diseases
Modalities: Monoclonal antibodies (mAbs), broad-spectrum neutralizing antibodiesAntibody therapeutics primarily for passive immunization against viral infections
Industry: Biotech

Drug pipeline

1 asset

Long-acting monoclonal antibodies for influenza A

Preclinical

Partnerships

AstraZeneca — exclusive worldwide license agreement for SARS-CoV‑2 mAbs including milestone payments up to $157 million plus royalties[4][6][10]University of Oxford — scientific collaboration and advisory support[4][6]LifeArc — UK medical research charity collaboration supporting development efforts[4][6]

Beyond the preview

Go deeper on RQ Biotechnology Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RQ Biotechnology Ltd.

Explore the full profile